يعرض 1 - 10 نتائج من 260 نتيجة بحث عن '"Berger, Marc G."', وقت الاستعلام: 0.99s تنقيح النتائج
  1. 1
    دورية أكاديمية
    Health-related quality of life and symptoms of chronic myeloid leukemia patients after discontinuation of tyrosine kinase inhibitors: results from the EURO-SKI Trial

    المؤلفون: Efficace, FabioAff1, IDs41375024023414_cor1, Mahon, Francois-Xavier, Richter, Johan, Piciocchi, Alfonso, Cipriani, MartaAff1, Aff4, Nicolini, Franck E., Mayer, Jiri, Zackova, Daniela, Janssen, Jeroen J. W. M., Panayiotidis, Panayiotis, Vestergaard, Hanne, Koskenvesa, Perttu, Almeida, AntonioAff11, Aff12, Hjorth-Hansen, Henrik, Martinez-Lopez, Joaquin, Olsson-Strömberg, Ulla, Hochhaus, Andreas, Berger, Marc G., Etienne, GabrielAff18, Aff19, Klamova, Hana, Faber, Edgar, Rousselot, Philippe, Pfirrmann, Markus, Saussele, Susanne

    المصدر: Leukemia. 38(8):1722-1730

    Find this article in full text from Springer Verlag. Full Text Finder
    أضف إلى المفضلة
  2. 2
    دورية أكاديمية
    Correction: Value of combining biological age with assessment of individual frailty to optimize management of cancer treated with targeted therapies: model of chronic myeloid leukemia treated with tyrosine kinase inhibitors (BIO-TIMER trial)

    المؤلفون: Casile, MélanieAff1, Aff3, IDs12885024125920_cor1, Albrand, Gilles, Lahaye, Clément, Lebecque, BenjaminAff1, Aff3, Besombes, JoévinAff1, Aff3, Bourgne, CélineAff1, Aff3, Pereira, Bruno, Saugues, SandrineAff1, Aff5, Jamot, CarolineAff1, Aff5, Hermet, Eric, Berger, Marc G.Aff1, Aff3, Aff5

    المصدر: BMC Cancer. 24(1)

    Find this article in full text from Springer Verlag. Find this article in full text from ProQuest Full Text Finder
    أضف إلى المفضلة
  3. 3
    دورية أكاديمية
    Value of combining biological age with assessment of individual frailty to optimize management of cancer treated with targeted therapies: model of chronic myeloid leukemia treated with tyrosine kinase inhibitors (BIO-TIMER trial)

    المؤلفون: Casile, MélanieAff1, Aff3, IDs12885024124152_cor1, Albrand, Gilles, Lahaye, Clément, Lebecque, BenjaminAff1, Aff3, Besombes, JoévinAff1, Aff3, Bourgne, CélineAff1, Aff3, Pereira, Bruno, Saugues, SandrineAff1, Aff5, Jamot, CarolineAff1, Aff5, Hermet, Eric, Berger, Marc G.Aff1, Aff3, Aff5

    المصدر: BMC Cancer. 24(1)

    Find this article in full text from Springer Verlag. Find this article in full text from ProQuest Full Text Finder
    أضف إلى المفضلة
  4. 4
    دورية أكاديمية
    Patient reported outcomes of patients with Gaucher disease type 1 treated with eliglustat in real-world settings: The ELIPRO study

    المؤلفون: Camou, Fabrice, Lagadec, Audrey, Coutinho, Angela, Berger, Marc G., Cador-Rousseau, Bérengère, Gaches, Francis, Belmatoug, Nadia

    المصدر: In Molecular Genetics and Metabolism November 2023 140(3)

    View record from ScienceDirect Full Text Finder
    أضف إلى المفضلة
  5. 5
    دورية أكاديمية

    لا يتم عرض هذه النتيجة على الضيوف.

    View this record from ISI Web of Science
    أضف إلى المفضلة
  6. 6
    دورية أكاديمية
    Real-world therapeutic response and tyrosine kinase inhibitor discontinuation in chronic phase-chronic myeloid leukemia: data from the French observatory

    المؤلفون: Saugues, SandrineAff1, Aff2, Lambert, Céline, Daguenet, Elisabeth, Ansah, Hyacinthe Johnson, Turhan, Ali, Huguet, Françoise, Guerci-Bresler, Agnès, Tchirkov, AndreïAff3, Aff9, Hamroun, Dalil, Hermet, Eric, Pereira, Bruno, Berger, Marc G.Aff1, Aff2, Aff11, IDs0027702204955z_cor12

    المصدر: Annals of Hematology. 101(10):2241-2255

    Find this article in full text from Springer Verlag. Find this article in full text from ProQuest Full Text Finder
    أضف إلى المفضلة
  7. 7
    دورية أكاديمية

    لا يتم عرض هذه النتيجة على الضيوف.

    View this record from ISI Web of Science
    أضف إلى المفضلة
  8. 8
    كتاب إلكتروني
    Contribution of Chronic Myeloid Leukaemia (CML) as a Disease Model to Define and Study Clonal Heterogeneity

    المؤلفون: Berger, Marc G.Aff4, Aff5, Aff6, Bourgne, CélineAff4, Aff5

    المساهمون: Lambris, John D., Series EditorAff1, Rezaei, Nima, Series EditorAff2, Birbrair, Alexander, editorAff3

    المصدر: Stem Cells Heterogeneity in Cancer. 1139:171-185

    أضف إلى المفضلة
  9. 9
    دورية أكاديمية
    Efficiency of nilotinib to target chronic phase-chronic myeloid leukaemia primary mature CD34− and immature CD34+ cells

    المؤلفون: Berger, Marc G.Aff1, Aff2, Aff3, Aff11, Lebecque, BenjaminAff1, Aff2, Tassin, ThomasAff1, Aff2, Dannus, Louis-ThomasAff1, Aff2, Berger, JulietteAff1, Aff2, Aff3, Soucal, MélanieAff1, Aff2, Guerci, Agnès, Cony-Makhoul, Pascale, Johnson, Hyacinthe, Etienne, Gabriel, Guyotat, Denis, Gagnieu, Marie-Claude, Pereira, Bruno, Saugues, SandrineAff2, Aff3, Tournilhac, OlivierAff2, Aff11, Hermet, Eric, Bourgne, CélineAff1, Aff2

    المصدر: Scientific Reports. 11(1)

    Find this article in full text from Springer Verlag. Find this article in full text from ProQuest Full Text Finder
    أضف إلى المفضلة
  10. 10
    دورية أكاديمية
    MNDA controls the expression of MCL-1 and BCL-2 in chronic lymphocytic leukemia cells

    المؤلفون: Bottardi, Stefania, Guieze, Romain, Bourgoin, Vincent, Fotouhi-Ardakani, Nasser, Dougé, Aurore, Darracq, Anaïs, Lakehal, Yahia A., Berger, Marc G., Mollica, Luigina, Bay, Jacques-Olivier, Omichinski, James G., Milot, Eric

    المصدر: In Experimental Hematology August 2020 88:68-82

    View record from ScienceDirect Full Text via ClinicalKey Full Text Finder
    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS – أرسل هذا البحث بالبريد الإلكتروني – حفظ البحث – جدول التنبيهات: لا شيء